𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anticholinergic therapy and dementia in patients with Parkinson's disease

✍ Scribed by Margarita Pondal; Teodoro Del Ser; Félix Bermejo


Publisher
Springer
Year
1996
Tongue
English
Weight
318 KB
Volume
243
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Hyperhomocysteinemia in levodopa-treated
✍ Stefano Zoccolella; Claudia dell'Aquila; Giovanni Abruzzese; Angelo Antonini; Ub 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

## Abstract Dementia is a frequent non‐motor feature of Parkinson's disease (PD). Elevated plasma homocysteine (Hcy) levels have been associated with both cognitive impairment and dementia. Increased Hcy levels have been observed in levodopa‐treated patients with PD. The objective of our study was

Pentagon drawing and neuropsychological
✍ Francesca Cormack; Dag Aarsland; Clive Ballard; Martin J. Tovée 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract ## Objectives Early and accurate diagnosis of Dementia with Lewy Bodies (DLB) to allow the appropriate clinical treatment is a priority, given reports of severe neuroleptic sensitivity and a preferential response to cholinesterase inhibitors in these patients. There have been suggestio

Visual symptoms in Parkinson's disease a
✍ Neil K. Archibald; Mike P. Clarke; Urs P. Mosimann; David J. Burn 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

## Abstract Visual symptoms are common in PD and PD dementia and include difficulty reading, double vision, illusions, feelings of presence and passage, and complex visual hallucinations. Despite the established prognostic implications of complex visual hallucinations, the interaction between cogni

Cholinergic and other neurotransmitter m
✍ Paul T. Francis; Elaine K. Perry 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

It is now 30 years since the beginning of intensive efforts to understand the neurotransmitter biochemistry of dementia as exemplified by Alzheimer's disease and such studies have led to the development of rational treatment strategies, which are continuing to benefit patients. However, as studies b